Research ArticleSpondyloarthritis
Open Access
Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years
Désirée van der Heijde, Mikkel Østergaard, John D. Reveille, Xenofon Baraliakos, Andris Kronbergs, David M. Sandoval, Xiaoqi Li, Hilde Carlier, David H. Adams and Walter P. Maksymowych
The Journal of Rheumatology March 2022, 49 (3) 265-273; DOI: https://doi.org/10.3899/jrheum.210471
Désirée van der Heijde
1D. van der Heijde, MD, Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands;
Mikkel Østergaard
2M. Østergaard, MD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark;
John D. Reveille
3J.D. Reveille, MD, Division of Rheumatology and Clinical Immunogenetics, University of Texas–McGovern Medical School, Houston, Texas, USA;
Xenofon Baraliakos
4X. Baraliakos, MD, Ruhr-University Bochum, Bochum, Germany, and Rheumazentrum Ruhrgebiet, Herne, Germany;
Andris Kronbergs
5A. Kronbergs, PhD, D.M. Sandoval, MD, X. Li, PhD, H. Carlier, MD, D.H. Adams, PhD, Eli Lilly and Company, Indianapolis, Indiana, USA;
David M. Sandoval
5A. Kronbergs, PhD, D.M. Sandoval, MD, X. Li, PhD, H. Carlier, MD, D.H. Adams, PhD, Eli Lilly and Company, Indianapolis, Indiana, USA;
Xiaoqi Li
5A. Kronbergs, PhD, D.M. Sandoval, MD, X. Li, PhD, H. Carlier, MD, D.H. Adams, PhD, Eli Lilly and Company, Indianapolis, Indiana, USA;
Hilde Carlier
5A. Kronbergs, PhD, D.M. Sandoval, MD, X. Li, PhD, H. Carlier, MD, D.H. Adams, PhD, Eli Lilly and Company, Indianapolis, Indiana, USA;
David H. Adams
5A. Kronbergs, PhD, D.M. Sandoval, MD, X. Li, PhD, H. Carlier, MD, D.H. Adams, PhD, Eli Lilly and Company, Indianapolis, Indiana, USA;
Walter P. Maksymowych
6W.P. Maksymowych, MD, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- Braun J,
- Baraliakos X,
- Deodhar A, et al.
- 7.↵
- Braun J,
- Baraliakos X,
- Hermann KG, et al.
- 8.↵
- van der Heijde D,
- Baraliakos X,
- Hermann KA, et al.
- 9.↵
- 10.↵
- van der Heijde D,
- Cheng-Chung Wei J,
- Dougados M, et al.
- 11.↵
- Deodhar A,
- Poddubnyy D,
- Pacheco-Tena C, et al.
- 12.↵
- Dougados M,
- Wei JC,
- Landewé R, et al.
- 13.↵
- 14.↵
- Landewé RB,
- Gensler LS,
- Poddubnyy D, et al.
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- Pedersen SJ,
- Sørensen IJ,
- Lambert RG, et al.
- 20.↵
In this issue
The Journal of Rheumatology
Vol. 49, Issue 3
1 Mar 2022
Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years
Désirée van der Heijde, Mikkel Østergaard, John D. Reveille, Xenofon Baraliakos, Andris Kronbergs, David M. Sandoval, Xiaoqi Li, Hilde Carlier, David H. Adams, Walter P. Maksymowych
The Journal of Rheumatology Mar 2022, 49 (3) 265-273; DOI: 10.3899/jrheum.210471
Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years
Désirée van der Heijde, Mikkel Østergaard, John D. Reveille, Xenofon Baraliakos, Andris Kronbergs, David M. Sandoval, Xiaoqi Li, Hilde Carlier, David H. Adams, Walter P. Maksymowych
The Journal of Rheumatology Mar 2022, 49 (3) 265-273; DOI: 10.3899/jrheum.210471